Duvakitug clinical trials
Also written SAR447189 and TEV-48574.
How each study uses duvakitug is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the duvakitug studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2026 (4)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 0
Sanofi (6) · Teva Branded Pharmaceutical Products R&D, Inc. (2) · Teva Branded Pharmaceutical Products R&D LLC (1)
Studies
Open first, then newest update. How each study uses duvakitug is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- A Study to Investigate Efficacy and Safety of Duvakitug in Adult Participants With Moderate to Severe Hidradenitis SuppurativaRecruitingPhase 2SanofiNCT07812116Written as Duvakitug
- An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 SubstratesNot yet recruitingPhase 1SanofiNCT07923383Written as Duvakitug
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruitingPhase 3SanofiNCT07184996Written as Duvakitug
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruitingPhase 3SanofiNCT07184944Written as Duvakitug
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruitingPhase 3SanofiNCT07184931Written as Duvakitug
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruitingPhase 3SanofiNCT07185009Written as Duvakitug
- A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseActive, not recruitingPhase 2Teva Branded Pharmaceutical Products R&D LLCNCT05668013Written as TEV-48574 Dose Regimen A
- A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseCompletedPhase 2Teva Branded Pharmaceutical Products R&D, Inc.NCT05499130Written as TEV-48574
- A Study to Test if TEV-48574 is Effective in Relieving AsthmaTerminatedPhase 2Teva Branded Pharmaceutical Products R&D, Inc.NCT04545385Written as TEV-48574
Codes
What other systems call duvakitug · ClinicalTrials.gg INT016058
- UNII (FDA) B2I7YTE4ZADUVAKITUGOne source FDA
- NCI Thesaurus C199032DuvakitugOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | B2I7YTE4ZA | DUVAKITUG | One source FDA |
| NCI Thesaurus | C199032 | Duvakitug | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.